Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

CervoMed (CRVO) FCF Margin (2023 - 2025)

Historic FCF Margin for CervoMed (CRVO) over the last 8 years, with Q3 2025 value amounting to 2004.29%.

  • CervoMed's FCF Margin fell 17540200.0% to 2004.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 404.64%, marking a year-over-year decrease of 2951900.0%. This contributed to the annual value of 169.76% for FY2024, which is 654900.0% down from last year.
  • CervoMed's FCF Margin amounted to 2004.29% in Q3 2025, which was down 17540200.0% from 370.63% recorded in Q2 2025.
  • Over the past 5 years, CervoMed's FCF Margin peaked at 60.65% during Q1 2024, and registered a low of 2004.29% during Q3 2025.
  • Moreover, its 3-year median value for FCF Margin was 114.06% (2023), whereas its average is 340.51%.
  • In the last 5 years, CervoMed's FCF Margin surged by 471200bps in 2024 and then crashed by -17540200bps in 2025.
  • Quarter analysis of 3 years shows CervoMed's FCF Margin stood at 101.92% in 2023, then plummeted by -265bps to 372.38% in 2024, then tumbled by -438bps to 2004.29% in 2025.
  • Its FCF Margin stands at 2004.29% for Q3 2025, versus 370.63% for Q2 2025 and 203.1% for Q1 2025.